You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Nov 1, 2025

Cheek Injection Model for Simultaneous Measurement of Pain and Itch-related Behaviors
Published on: September 27, 2019
Huasheng Yu1, Kirk Wangensteen2, Tong Deng3
1Department of Neuroscience, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Cholestatic itch, a severe symptom of liver disease, may be caused by bile acids and bilirubin acting on the Mas-related G protein-coupled receptor X4 (MRGPRX4). This discovery offers a new target for developing effective anti-itch therapies.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: